SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 31, Issue 10, 2013, Pages 1262-1266

Acute myeloid leukemia in first remission: To choose transplantation or not?

(1) Stone, Richard M a

a HARVARD MEDICAL SCHOOL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CD33 ANTIGEN; CEBP ALPHA PROTEIN; CYTARABINE; DAUNORUBICIN; MEMBRANE PROTEIN; MICROSOMAL AMINOPEPTIDASE; NUCLEOPHOSMIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BONE MARROW EXAMINATION; CASE REPORT; CYTOGENETICS; FATIGUE; FEMALE; GENE MUTATION; GRAM NEGATIVE SEPSIS; HLA SYSTEM; HUMAN; KARYOTYPE; LABORATORY TEST; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MONOCYTE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SKIN BRUISING; WILD TYPE;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DAUNORUBICIN; DECISION MAKING; FEMALE; HUMANS; LEUKEMIA, MYELOID; PATIENT PREFERENCE; REMISSION INDUCTION; REVIEW LITERATURE AS TOPIC; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84876095248 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2012.43.4258 Document Type: Article

Times cited : (27)

References (14)

1
- 84863393263
- Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
- Patel JP, Gönen M, Figueroa ME, et al: Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 366:1079-1089, 2012
- (2012) N Engl J Med , vol.366 , pp. 1079-1089
- Patel, J.P.¹ Gönen, M.² Figueroa, M.E.³

2
- 0034672269
- Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study
- Slovak ML, Kopecky KJ, Cassileth PA, et al: Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96:4075-4083, 2000
- (2000) Blood , vol.96 , pp. 4075-4083
- Slovak, M.L.¹ Kopecky, K.J.² Cassileth, P.A.³

3
- 77449159028
- Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel on behalf of the European LeukemiaNet
- Döhner H, Estey EH, Amadori S, et al: Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel on behalf of the European LeukemiaNet. Blood 115:483-474, 2010
- (2010) Blood , vol.115 , pp. 483-1474
- Döhner, H.¹ Estey, E.H.² Amadori, S.³

4
- 79952129510
- Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: Myths, controversies, and unknowns
- Gupta V, Tallman MS, Weisdorf DJ: Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: Myths, controversies, and unknowns. Blood 117:2307-2318, 2011
- (2011) Blood , vol.117 , pp. 2307-2318
- Gupta, V.¹ Tallman, M.S.² Weisdorf, D.J.³

5
- 84876087623
- Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission
- Burnett AK, Goldstone A, Hills RK, et al: Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission. J Clin Oncol 31:1293-1301, 2013
- (2013) J Clin Oncol , vol.31 , pp. 1293-1301
- Burnett, A.K.¹ Goldstone, A.² Hills, R.K.³

6
- 9844244021
- Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia
- Harousseau JL, Cahn JY, Pignon B, et al: Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood 90:2978-2986, 1997 (Pubitemid 27444191)
- (1997) Blood , vol.90 , Issue.8 , pp. 2978-2986
- Harousseau, J.-L.¹ Cahn, J.-Y.² Pignon, B.³ Witz, F.⁴ Milpied, N.⁵ Delain, M.⁶ Lioure, B.⁷ Lamy, T.⁸ Desablens, B.⁹ Guilhot, F.¹⁰ Caillot, D.¹¹ Abgrall, J.-F.¹² Francois, S.¹³ Briere, J.¹⁴ Guyotat, D.¹⁵ Casassus, P.¹⁶ Audhuy, B.¹⁷ Tellier, Z.¹⁸ Hurteloup, P.¹⁹ Herve, P.²⁰ more..

7
- 0032480930
- Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
- DOI 10.1056/NEJM199812033392301
- Cassileth PA, Harrington DP, Appelbaum FR, et al: Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 339:1649-1656, 1998 (Pubitemid 28550689)
- (1998) New England Journal of Medicine , vol.339 , Issue.23 , pp. 1649-1656
- Cassileth, P.A.¹ Harrington, D.P.² Appelbaum, F.R.³ Lazarus, H.M.⁴ Rowe, J.M.⁵ Paietta, E.⁶ Willman, C.⁷ Hurd, D.D.⁸ Bennett, J.M.⁹ Blume, K.G.¹⁰ Head, D.R.¹¹ Wiernik, P.H.¹²

8
- 0028889993
- Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogeneous leukemia
- Zittoun RA, Mandelli F, Willemze R, et al: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogeneous leukemia. N Engl J Med 332:217-223, 1995
- (1995) N Engl J Med , vol.332 , pp. 217-223
- Zittoun, R.A.¹ Mandelli, F.² Willemze, R.³

9
- 0027941369
- Intensive postremission chemotherapy in adults with acute myeloid leukemia
- DOI 10.1056/NEJM199410063311402
- Mayer RJ, Davis RB, Schiffer CA, et al: Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903, 1994 (Pubitemid 24299870)
- (1994) New England Journal of Medicine , vol.331 , Issue.14 , pp. 896-903
- Mayer, R.J.¹ Davis, R.B.² Schiffer, C.A.³ Berg, D.T.⁴ Powell, B.L.⁵ Schulman, P.⁶ Omura, G.A.⁷ Moore, J.O.⁸ McIntyre, O.R.⁹ Frei III, E.¹⁰

10
- 42949142189
- Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
- DOI 10.1056/NEJMoa074306
- Schlenk RF, Döhner K, Krauter J, et al: Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358:1909-1918, 2008 (Pubitemid 351620111)
- (2008) New England Journal of Medicine , vol.358 , Issue.18 , pp. 1909-1918
- Schlenk, R.F.¹ Dohner, K.² Krauter, J.³ Frohling, S.⁴ Corbacioglu, A.⁵ Bullinger, L.⁶ Habdank, M.⁷ Spath, D.⁸ Morgan, M.⁹ Benner, A.¹⁰ Schlegelberger, B.¹¹ Heil, G.¹² Ganser, A.¹³ Dohner, H.¹⁴

11
- 33745185595
- Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia
- Yanada M, Matsuo K, Suzuki T, et al: Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia. Cancer 106:2657-2663, 2006
- (2006) Cancer , vol.106 , pp. 2657-2663
- Yanada, M.¹ Matsuo, K.² Suzuki, T.³

12
- 34247325560
- Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: Benefits for whom?
- DOI 10.1182/blood-2006-06-025627
- Cornelissen JJ, van Putten WL, Verdonck LF, et al: Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: Benefits for whom? Blood 109:3658-3666, 2007 (Pubitemid 46641712)
- (2007) Blood , vol.109 , Issue.9 , pp. 3658-3666
- Cornelissen, J.J.¹ Van Putten, W.L.J.² Verdonck, L.F.³ Theobald, M.⁴ Jacky, E.⁵ Daenen, S.M.G.⁶ Van Marwijk, K.M.⁷ Wijermans, P.⁸ Schouten, H.⁹ Huijgens, P.C.¹⁰ Van Der, L.H.¹¹ Fey, M.¹² Ferrant, A.¹³ Maertens, J.¹⁴ Gratwohl, A.¹⁵ Lowenberg, B.¹⁶

13
- 67049164836
- Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systemic review and meta-analysis of prospective clinical trials
- Koreth J, Schlenk R, Kopecky KJ, et al: Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systemic review and meta-analysis of prospective clinical trials. JAMA 301:2349-2361, 2009
- (2009) JAMA , vol.301 , pp. 2349-2361
- Koreth, J.¹ Schlenk, R.² Kopecky, K.J.³

14
- 33748467435
- Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8; 21): A Cancer and Leukemia Group B study
- Paschka P, Marcucci G, Ruppert A, et al: Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8; 21): A Cancer and Leukemia Group B study. J Clin Oncol 24:3904-3910, 2006
- (2006) J Clin Oncol , vol.24 , pp. 3904-3910
- Paschka, P.¹ Marcucci, G.² Ruppert, A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.